Search for:

Home
About
Where we work
News
Strategies
Resources

Where we work
- Argentina
- Armenia
- Bangladesh
- Belarus
- Brazil
- El Salvador
- Georgia
- Guatemala
- Honduras
- India
- Indonesia
- Kazakhstan
- Kenya
- Kyrgyzstan
- Moldova
- Morocco
- Mozambique
- Myanmar
- Russia
- Thailand
- Uganda
- Ukraine
- Vietnam
- Zimbabwe

Mozambique

Country info coming soon.

Keep in Touch

Our email newsletter has latest news on developments and campaign actions

Subscribe to our mailing list

Twitter

RT @GlobalJusticeUK: "I joined this research trial out of solidarity and a belief in the common good. But I'm worried that this publicly-fu…
5 days ago

Make Medicines Affordable Twitter

Facebook

Russian NGOs have opposed Gilead's patent on Truvada (TDF/FTC), recommended for HIV treatment, and as PrEP.
Russia pays around 40x more for Gilead's overpriced branded version: $200 per month, compared to $5 per month for quality-assured generic versions.
If the court revokes the patent it will save money and lives.
The next hearing is September 2020.
makemedicinesaffordable.org/russian-ngos-oppose-gileads-patent-for-hiv-drug-truvada/ ... See MoreSee Less

5 days ago ·

Photo

ITPC global Facebook

Website by Maraid Design